Form 8-K - Current report:
SEC Accession No. 0001558370-21-012862
Filing Date
2021-09-29
Accepted
2021-09-29 09:05:48
Documents
14
Period of Report
2021-09-29
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K edit-20210929x8k.htm   iXBRL 8-K 39971
2 EX-99.1 edit-20210929xex99d1.htm EX-99.1 20775
3 GRAPHIC edit-20210929xex99d1001.jpg GRAPHIC 4566
  Complete submission text file 0001558370-21-012862.txt   194706

Data Files

Seq Description Document Type Size
4 EX-101.SCH edit-20210929.xsd EX-101.SCH 2999
5 EX-101.LAB edit-20210929_lab.xml EX-101.LAB 15384
6 EX-101.PRE edit-20210929_pre.xml EX-101.PRE 9975
7 EXTRACTED XBRL INSTANCE DOCUMENT edit-20210929x8k_htm.xml XML 4678
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37687 | Film No.: 211289561
SIC: 2836 Biological Products, (No Diagnostic Substances)